Bicuspid aortic valve stenosis is characterized by increased angiogenesis, inflammation, and a higher valvular-to-systemic calcification ratio than tricuspid aortic valve stenosis - Report - MDSpire

Bicuspid aortic valve stenosis is characterized by increased angiogenesis, inflammation, and a higher valvular-to-systemic calcification ratio than tricuspid aortic valve stenosis

  • By

  • Alexander Brückner

  • Adrian Brandtner

  • Sarah Rieck

  • Hannah Billig

  • Werner Masson

  • Anna Weber

  • Farhad Bakhtiary

  • Wilhelm Röll

  • Christoph Bourauel

  • Frank A. Schildberg

  • Baravan Al-Kassou

  • Sebastian Zimmer

  • Daniela Wenzel

  • Bernd K. Fleischmann

  • June 27, 2026

  • 0 min

Share

Bicuspid Aortic Valve Stenosis Exhibits Heightened Angiogenesis and Inflammation

Overview

This study identifies significant differences between bicuspid aortic valve stenosis (bAVS) and tricuspid aortic valve stenosis (AVS), highlighting increased angiogenesis, inflammation, and calcification in bAVS.

Background

Aortic valve stenosis is a prevalent condition, particularly in the elderly, often leading to severe complications such as heart failure. Understanding the differences between bAVS and AVS is crucial, as bAVS typically affects younger patients and is associated with unique pathophysiological features.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Bicuspid aortic valve stenosis (bAVS) shows enhanced inflammation compared to tricuspid aortic valve stenosis (AVS).
  • Increased angiogenesis is observed in bAVS.
  • Localized calcification is more pronounced in bAVS, contrasting with systemic vascular calcification in AVS.
  • Differences in valve morphology and biomechanics contribute to the distinct pathophysiology of bAVS and AVS.

Clinical Implications

Clinicians should consider the differences between bAVS and AVS when evaluating treatment options for patients with aortic valve stenosis.

Conclusion

Further research is warranted to explore the underlying molecular mechanisms.

Related Resources & Content

  1. Basic Research in Cardiology, 2022 -- The Role of Innate Immune Cells in Calcific Aortic Valve Disease Pathophysiology: Insights from Atherosclerotic Cardiovascular Disease
  2. Clinical Research in Cardiology, 2024 -- Factors Influencing Ongoing Ascending Aortic Dilation Following TAVI in Patients with Bicuspid Aortic Stenosis
  3. Clinical Research in Cardiology, 2026 -- Prognostic impact of iliofemoral access-site calcification volume on outcomes after transcatheter aortic valve implantation
  4. British Journal of Biomedical Science -- Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease
  5. 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
  6. BAV-0 Associated With Better Long-Term Prognosis in Patients With Severe AS Undergoing TAVR - American College of Cardiology
  7. Transcriptomic Signatures of Calcific Aortic Valve Stenosis Severity in Human Tricuspid and Bicuspid Aortic Valves - ScienceDirect
  8. https://inavalverhd.inaheart.org/wp-content/uploads/2025/09/2025-ESC-EACTS-Guidelines-for-the-Management-of-Valvular-Heart-Disease.pdf
  9. BAV-0 Associated With Better Long-Term Prognosis in Patients With Severe AS Undergoing TAVR - American College of Cardiology
  10. Transcriptomic Signatures of Calcific Aortic Valve Stenosis Severity in Human Tricuspid and Bicuspid Aortic Valves - ScienceDirect

Original Source(s)

Related Content